亚洲国内自拍中文|国产在线高清在线精品|国产亚洲福利在线午夜|亚洲视频高清不卡在线观看|无码国产精品一区二区vr|国产91精选在线观看网站|亚洲欧美综合图区日韩gif|亚洲码欧美码一区二区三区四区,穿越小说完本,已完结小说排行榜,盗墓笔记同人小说

Welcome to Linuo Group!HomeBusiness License
  • CN

  • WeChat

  • Mobile Site

  • Search

力諾產(chǎn)業(yè)

Shandong Keyuan Pharmaceutical Co., Ltd.

2017.09.19

Founded in 2004, Shandong Keyuan Pharmaceutical Co., Ltd. is the core member of Linuo Healthcare Industry. It is a high-tech company dedicated to the R&D, manufacture and sales of APIs. Its portfolio covers anti-diabetic agents, cardiovascular agents and anesthetics. Keyuan has established strategic partnership with many renowned international companies.  
The company consistently upholds the entrepreneurship and practical working style. With the accumulative industrial strength and the technology-guided and people-oriented business principle, the company has gradually become the backbone of Shandong synthetic API industry.  
The company produces gliclazide, metformin hydrochloride, isosorbide mononitrate, isosorbide dinitrate, isoclurance, ropivacaine hydrochloride and clarithromycin lactobionate.
Main accreditations: gliclazide, isosorbide monoitrate mixed powder and other products have obtained the accreditation of CEP. PLNS has obtained the accreditation of FDA.
In March 2016, Keyuan was listed on NEEQ. NEEQ varies the choice of investment and expands the withdrawal of venture investment institutions. Being listed on NEEQ provides more financing channels for the company, expanding the financing platform, and make the financing more flexible, which lays an increasingly solid foundation for the further development of the company and strengthens its international competitiveness. Keyuan will make itself a larger and stronger company with the help of the capital market.
Keyuan upholds the motto of Serving the country with industry and striving for excellence and is devoted to establishing the largest production base of anti-diabetic agents, cardiovascular agents and anesthetics for the benefit of the patients.